Burhanuddin Sabuwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Burhanuddin Sabuwala has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Gisela Gabernet
Department of Pathology, Yale School of Medicine
2 shared publications - Steven H. Kleinstein
Yale School of Medicine, New Haven, USA
2 shared publications - Arne Gehlhaar
Oxford Vaccine Group, Department of Paediatrics, University of Oxford
1 shared publication - Carrie L. Lucas
Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
1 shared publication - Chino Eke
Division of Plastic Surgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
1 shared publication - Edel Aron
Program in Computational Biology and Biomedical Informatics, Yale University
1 shared publication
Latest Publications
- Open Access
Cell-level integration of gene expression and B cell receptor data captures complementary B cell information
Single-cell B cell analyses commonly define relationships among cells using gene expression (GEX), although paired B cell receptor (BCR) sequences provide complementary information about receptor features, differentiation, and clonal relationships. We evaluated multiple approaches for integrating paired GEX and BCR data into cell-level representations and compared their ability to capture complementary aspects of B cell biology. We compared BCR representations based on language-model embeddings and engineered sequence features across multiple integration strategies. Spaces dominated by BCR language-model embeddings captured broad sequence and clonal information but could distort cell type relationships, as assessed using independent cell surface protein measurements. In contrast, concatenating GEX with selected BCR features (isotype, somatic hypermutation frequency, and CDRH3 length) incorporated receptor information while retaining transcriptional and surface-protein-associated structure. The resulting space reduced discordance between GEX-based cell type annotations and BCR characteristics and revealed B-cell substructure supported by both transcriptional and receptor-derived features. Thus, integrating GEX and BCR data captures complementary biological information and provides a richer foundation for single-cell B cell analysis.
Open AccessCell-level integration of gene expression and B cell receptor data captures complementary B cell information
Single-cell B cell analyses commonly define relationships among cells using gene expression (GEX), although paired B cell receptor (BCR) sequences provide complementary information about receptor features, differentiation, and clonal relationships. We evaluated multiple approaches for integrating paired GEX and BCR data into cell-level representations and compared their ability to capture complementary aspects of B cell biology. We compared BCR representations based on language-model embeddings and engineered sequence features across multiple integration strategies. Spaces dominated by BCR language-model embeddings captured broad sequence and clonal information but could distort cell type relationships, as assessed using independent cell surface protein measurements. In contrast, concatenating GEX with selected BCR features (isotype, somatic hypermutation frequency, and CDRH3 length) incorporated receptor information while retaining transcriptional and surface-protein-associated structure. The resulting space reduced discordance between GEX-based cell type annotations and BCR characteristics and revealed B-cell substructure supported by both transcriptional and receptor-derived features. Thus, integrating GEX and BCR data captures complementary biological information and provides a richer foundation for single-cell B cell analysis.
- 5 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (788) , eadr0942
A single-cell atlas of circulating immune cells over the first 2 months of age in extremely premature infants
Extremely premature infants (EPIs) who are born before 30 weeks of gestation are susceptible to infection; however, the trajectory of their peripheral immunity is poorly understood. Here, we undertook longitudinal analyses of immune cells from 250 μl of whole blood at 1 week, 1 month, and 2 months from 10 EPIs and compared these with samples from healthy adults and with preterm and full-term cord blood samples. Single-cell suspensions from individual samples were split to perform single-cell RNA sequencing, T and B cell receptor sequencing, and phosphoprotein mass cytometry. The trajectories of circulating T, B, myeloid, and natural killer cells in EPIs over the first 2 months of life were distinct from those of full-term infants. In EPIs, peripheral T cell development rapidly progressed over the first month of life, with an increase in the proportion of naïve CD4 + , regulatory, and cycling T cells, accompanied by greater STAT5 (signal transducer and activator of transcription 5) signaling. EPI memory CD4 + T cells showed a T helper 1 (T H 1) predominance compared with T H 2 skewing of central memory–like T cells in full-term infants, and B cells from 2-month-old EPIs exhibited increased signatures of activation and differentiation. Both B and T cells from 2-month-old EPIs displayed increased interferon signatures compared with cells from full-term infants. In conclusion, we demonstrated the feasibility of longitudinal multiomic analyses in EPIs using minute amounts of blood and developed a resource describing peripheral immune development in EPIs that suggested ongoing activation in early life.
- 5 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (788) , eadr0942
A single-cell atlas of circulating immune cells over the first 2 months of age in extremely premature infants
Extremely premature infants (EPIs) who are born before 30 weeks of gestation are susceptible to infection; however, the trajectory of their peripheral immunity is poorly understood. Here, we undertook longitudinal analyses of immune cells from 250 μl of whole blood at 1 week, 1 month, and 2 months from 10 EPIs and compared these with samples from healthy adults and with preterm and full-term cord blood samples. Single-cell suspensions from individual samples were split to perform single-cell RNA sequencing, T and B cell receptor sequencing, and phosphoprotein mass cytometry. The trajectories of circulating T, B, myeloid, and natural killer cells in EPIs over the first 2 months of life were distinct from those of full-term infants. In EPIs, peripheral T cell development rapidly progressed over the first month of life, with an increase in the proportion of naïve CD4 + , regulatory, and cycling T cells, accompanied by greater STAT5 (signal transducer and activator of transcription 5) signaling. EPI memory CD4 + T cells showed a T helper 1 (T H 1) predominance compared with T H 2 skewing of central memory–like T cells in full-term infants, and B cells from 2-month-old EPIs exhibited increased signatures of activation and differentiation. Both B and T cells from 2-month-old EPIs displayed increased interferon signatures compared with cells from full-term infants. In conclusion, we demonstrated the feasibility of longitudinal multiomic analyses in EPIs using minute amounts of blood and developed a resource describing peripheral immune development in EPIs that suggested ongoing activation in early life.